Literature DB >> 22476418

[Bone tissue engineering. Reconstruction of critical sized segmental bone defects in the ovine tibia].

J C Reichert1, D R Epari, M E Wullschleger, A Berner, S Saifzadeh, U Nöth, I C Dickinson, M A Schuetz, D W Hutmacher.   

Abstract

Well-established therapies for bone defects are restricted to bone grafts which face significant disadvantages (limited availability, donor site morbidity, insufficient integration). Therefore, the objective was to develop an alternative approach investigating the regenerative potential of medical grade polycaprolactone-tricalcium phosphate (mPCL-TCP) and silk-hydroxyapatite (silk-HA) scaffolds.Critical sized ovine tibial defects were created and stabilized. Defects were left untreated, reconstructed with autologous bone grafts (ABG) and mPCL-TCP or silk-HA scaffolds. Animals were observed for 12 weeks. X-ray analysis, torsion testing and quantitative computed tomography (CT) analyses were performed. Radiological analysis confirmed the critical nature of the defects. Full defect bridging occurred in the autograft and partial bridging in the mPCL-TCP group. Only little bone formation was observed with silk-HA scaffolds. Biomechanical testing revealed a higher torsional moment/stiffness (p < 0.05) and CT analysis a significantly higher amount of bone formation for the ABG group when compared to the silk-HA group. No significant difference was determined between the ABG and mPCL-TCP groups. The results of this study suggest that mPCL-TCP scaffolds combined can serve as an alternative to autologous bone grafting in long bone defect regeneration. The combination of mPCL-TCP with osteogenic cells or growth factors represents an attractive means to further enhance bone formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476418     DOI: 10.1007/s00132-011-1855-x

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  33 in total

1.  Tissue-engineered bone regeneration.

Authors:  H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

2.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

Authors:  Hongwei Cheng; Wei Jiang; Frank M Phillips; Rex C Haydon; Ying Peng; Lan Zhou; Hue H Luu; Naili An; Benjamin Breyer; Pantila Vanichakarn; Jan Paul Szatkowski; Jae Yoon Park; Tong-Chuan He
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

Review 3.  State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective.

Authors:  Dietmar Werner Hutmacher; Jan Thorsten Schantz; Christopher Xu Fu Lam; Kim Cheng Tan; Thiam Chye Lim
Journal:  J Tissue Eng Regen Med       Date:  2007 Jul-Aug       Impact factor: 3.963

4.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

5.  The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction.

Authors:  G A Ilizarov
Journal:  Clin Orthop Relat Res       Date:  1989-02       Impact factor: 4.176

6.  Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow.

Authors:  Frank C den Boer; Burkhard W Wippermann; Taco J Blokhuis; Peter Patka; Fred C Bakker; Henk J Th M Haarman
Journal:  J Orthop Res       Date:  2003-05       Impact factor: 3.494

7.  Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2).

Authors:  Kun Na; Sung Won Kim; Bo Kyung Sun; Dae Gyun Woo; Han Na Yang; Hyung Min Chung; Keun Hong Park
Journal:  Biomaterials       Date:  2007-02-28       Impact factor: 12.479

8.  Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.

Authors:  Neil M Blumenthal; Grace Koh-Kunst; Mario E A F Alves; Dario Miranda; Rachel G Sorensen; John M Wozney; Ulf M E Wikesjö
Journal:  J Periodontol       Date:  2002-12       Impact factor: 6.993

9.  Effect of bioactive ceramic composition and structure on in vitro behavior. III. Porous versus dense ceramics.

Authors:  S R Radin; P Ducheyne
Journal:  J Biomed Mater Res       Date:  1994-11

10.  Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria.

Authors:  I Asahina; T K Sampath; I Nishimura; P V Hauschka
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more
  4 in total

1.  Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model.

Authors:  Arne Berner; Jan Henkel; Maria A Woodruff; Roland Steck; Michael Nerlich; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Stem Cells Transl Med       Date:  2015-04-01       Impact factor: 6.940

Review 2.  Animal models for bone tissue engineering and modelling disease.

Authors:  Jacqui Anne McGovern; Michelle Griffin; Dietmar Werner Hutmacher
Journal:  Dis Model Mech       Date:  2018-04-23       Impact factor: 5.758

Review 3.  Recent developments in biomaterials for long-bone segmental defect reconstruction: A narrative overview.

Authors:  Meng Zhang; Jukka P Matinlinna; James K H Tsoi; Wenlong Liu; Xu Cui; William W Lu; Haobo Pan
Journal:  J Orthop Translat       Date:  2019-10-08       Impact factor: 5.191

4.  Different Culture Media Affect Proliferation, Surface Epitope Expression, and Differentiation of Ovine MSC.

Authors:  Carina Adamzyk; Tanja Emonds; Julia Falkenstein; René Tolba; Wilhelm Jahnen-Dechent; Bernd Lethaus; Sabine Neuss
Journal:  Stem Cells Int       Date:  2013-10-21       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.